Home › Schizophrenia › New York
Schizophrenia clinical trials in New York
23 studies for Schizophrenia are looking for participants at sites in New York.
Cities in New York
iTBS to Enhance Social Cognition in People With Psychosis
- Zucker Hillside Hospital, Glen Oaks
Recruiting
Ages 18 to 39 · All sexes · Updated Oct 1, 2026 · NCT06118268Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Radial - Manhattan, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Neurobehavioral Research Inc, Cedarhurst
- Evolution Research Group, Staten Island
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 28, 2026 · NCT07615426Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- NYU Child Study Center, New York
- Richmond Behavioral Associates, Staten Island
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
- and 2 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, The Bronx
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0061, Great Neck
- Local Institution - 0156, Staten Island
- Local Institution - 0151, The Bronx
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Harlem, New York
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT0741050752-week Open Label Safety-Tolerability Study
- Neuro-Behavioral Clinical Research, New York
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0061, Great Neck
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0037, Buffalo
- Local Institution - 0004, Monsey
- Local Institution - 0038, Rochester
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, New York
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064Biomarkers to Enhance Early Schizophrenia Treatment
- Feinstein Institute for Medical Research, Glen Oaks
RecruitingPhase 4
Ages 18 to 35 · All sexes · Updated Jul 31, 2026 · NCT06969755MicroRNAs as Biomarkers in First Episode Schizophrenia
- Zucker Hillside Hospital, Glen Oaks
RecruitingHealthy volunteers welcome
Ages 15 to 40 · All sexes · Updated Jul 14, 2026 · NCT07703670A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
- Manhattan Psychiatric Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains
Recruiting
Ages 18 to 64 · All sexes · Updated Jun 10, 2026 · NCT07434479Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- NYU Langone Medical Center, New York
- New York State Psychiatric Institute, New York
- Manhattan Psychiatric Center, New York
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT05208190NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Staten Island
- Neurocrine Clinical Site, The Bronx
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Staten Island
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5108, New York
- Site 5077, New York
- Site 5126, White Plains
RecruitingPhase 2
Ages 21 to 55 · All sexes · Updated Dec 26, 2025 · NCT06502964Visual Perception in Schizophrenia
- University of Rochester, Rochester
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 12, 2025 · NCT06911931Effectiveness of Motivation Skills Training (MST)
- The Bridge, Inc., New York
- New York State Office of Mental Health, New York
Recruiting
Ages 18 to 65 · All sexes · Updated Nov 5, 2025 · NCT05805397Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
- Zucker Hillside Hospital, New York
Recruiting
Ages 18 to 60 · All sexes · Updated Sep 25, 2025 · NCT05389787From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.